Akero Therapeutics Inc.
(AKRO)
undefined
undefined%
At close: undefined
28.24
0.07%
After-hours Jan 03, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 29.00K | 260.00K | 244.00K | 213.00K | n/a | n/a | n/a |
| Gross Profit | -29.00K | -260.00K | -244.00K | -213.00K | n/a | n/a | n/a |
| Operating Income | -172.87M | -115.16M | -100.89M | -80.15M | -45.65M | -13.78M | -4.56M |
| Interest Income | 24.21M | 3.86M | 109.00K | 947.00K | 1.90M | n/a | n/a |
| Pretax Income | -151.76M | -112.03M | -100.78M | -79.21M | -43.76M | -81.71M | -4.56M |
| Net Income | -151.76M | -108.91M | -100.74M | -79.19M | -43.76M | -81.71M | -4.56M |
| Selling & General & Admin | 31.07M | 29.87M | 19.13M | 15.24M | 8.61M | 1.90M | 1.08M |
| Research & Development | 141.80M | 85.28M | 81.76M | 64.92M | 37.05M | 11.88M | 3.49M |
| Other Expenses | n/a | 3.86M | 109.00K | 947.00K | 1.90M | -67.94M | n/a |
| Operating Expenses | 172.87M | 115.16M | 100.89M | 80.15M | 45.65M | 13.78M | 4.56M |
| Interest Expense | 3.10M | 739.00K | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -98.00K |
| Cost & Expenses | 172.87M | 115.16M | 100.89M | 80.15M | 45.65M | 13.78M | 4.56M |
| Income Tax | n/a | -3.12M | -41.00K | -17.00K | 24.00K | -68.10M | -4.98M |
| Shares Outstanding (Basic) | 52.57M | 38.98M | 34.83M | 31.46M | 15.07M | 21.22M | 28.56M |
| Shares Outstanding (Diluted) | 52.57M | 38.98M | 34.83M | 31.46M | 15.07M | 21.22M | 28.56M |
| EPS (Basic) | -2.89 | -2.79 | -2.89 | -2.52 | -2.9 | -3.85 | -0.16 |
| EPS (Diluted) | -2.89 | -2.79 | -2.89 | -2.52 | -2.9 | -3.85 | -0.16 |
| EBITDA | -148.63M | -111.03M | -100.53M | -78.99M | -45.65M | -68.46M | -232.36K |
| Depreciation & Amortization | 29.00K | 260.00K | 244.00K | 213.00K | -104.00K | 13.78M | 4.98M |